Hoth Therapeutics is a development stage biopharmaceutical company focused on targeted therapeutics for patients suffering from indications such as atopic dermatitis. The Company also develops the BioLexa Platform, a product candidate intended to prevent the symptom-triggering flare-ups before they occur.
|HQ||New York, US||Map|
|Employees (est.) (Mar 2019)||2|
|Share Price (Nov 2019)||$4.3||(-3%)|
Net income (Q2, 2019)
EBIT (Q2, 2019)
Market capitalization (15-Nov-2019)
Closing stock price (15-Nov-2019)
How many employees does Hoth Therapeutics have?
Hoth Therapeutics has 2 employees.
Who are Hoth Therapeutics competitors?
Competitors of Hoth Therapeutics include Synthorx, Innovation Pharmaceuticals and Veloxis Pharmaceuticals.
Where is Hoth Therapeutics headquarters?
Hoth Therapeutics headquarters is located at 1 Rockefeller Plaza, 10th Floor, New York.
Where are Hoth Therapeutics offices?
Hoth Therapeutics has an office in New York.
How many offices does Hoth Therapeutics have?
Hoth Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies